Iqvia Holdings Inc. (IQV): Total Assets

Annual figures by period end, from SEC filings.

$29.94B
As of 2025-12-31
$29.68B
As of 2026-03-31
+5.7%
3-year compound annual growth
+4.0%
5-year compound annual growth
+22.5%
10-year compound annual growth
2011-12-31: $2.32B2012-12-31: $2.50B2013-12-31: $3.05B2014-12-31: $3.30B2015-12-31: $3.93B2016-12-31: $21.21B2017-12-31: $22.86B2018-12-31: $22.55B2019-12-31: $23.25B2020-12-31: $24.56B2021-12-31: $24.69B2022-12-31: $25.34B2023-12-31: $26.68B2024-12-31: $26.90B2025-12-31: $29.94B$29.94B
2011-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$29.94B+11.3%2026-02-17, Balance as of period end
2024-12-31$26.90B+0.8%2026-02-17, Balance as of period end
2023-12-31$26.68B+5.3%2025-02-13, Balance as of period end
2022-12-31$25.34B+2.6%2024-02-15, Balance as of period end
2021-12-31$24.69B+0.5%2023-02-15, Balance as of period end
2020-12-31$24.56B+5.6%2022-02-16, Balance as of period end
2019-12-31$23.25B+3.1%2021-02-12, Balance as of period end
2018-12-31$22.55B-1.3%2020-02-18, Balance as of period end
2017-12-31$22.86B+7.8%2019-02-19, Balance as of period end
2016-12-31$21.21B+440.2%2018-02-16, Balance as of period end
2015-12-31$3.93B+19.1%2017-02-16, Balance as of period end
2014-12-31$3.30B+7.9%2016-02-11, Balance as of period end
2013-12-31$3.05B+22.2%2016-02-11, Balance as of period end
2012-12-31$2.50B+7.6%2015-02-12, Balance as of period end
2011-12-31$2.32Bn/a2014-02-13, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$29.94B+11.3%
Icon PLC (ICLR)2025-12-31$16.27B-2.2%
Incyte Corp (INCY)2025-12-31$6.96B+27.8%
Charles River Laboratories International, Inc. (CRL)2025-12-27$7.14B-5.2%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.98B-6.0%
NRC Health (NRC)2025-12-31$134.88M+1.8%
MaxCyte, Inc. (MXCT)2025-12-31$202.51M-15.4%
OmniAb, Inc. (OABI)2025-12-31$300.91M-7.6%
Foxo Technologies Inc. (FOXO)2025-12-31$44.58M+6.9%

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗